Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in XPH
28.6%
% of XPH's 42 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 5.7% | 4.3% | 4.3% |
|
ZOETIS INC | 4.7% | 3.5% | 3.5% |
|
JOHNSON & JOHNSON | 6.4% | 3.3% | 3.3% |
|
MERCK & CO. INC. | 5.0% | 3.3% | 3.3% |
|
PFIZER INC | 4.3% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 9.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 8.1% |
|
ABBVIE INC | 5.9% |
|
MCKESSON CORP | 5.6% |
|
AMERISOURCEBERGEN CORP | 4.9% |
 |
NOVARTIS AG-ADR | 4.7% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.5% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 3.9% |
PPH Underweight Relative to XPH
|
CORCEPT THERAPEUTICS INC | -5.5% |
|
INTRA-CELLULAR THERAPIES INC | -4.2% |
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
ROYALTY PHARMA PLC CLASS A | -3.4% |
 |
PERRIGO CO | -3.2% |
|
EDGEWISE THERAPEUTICS, INC. | -3.2% |
|
JAZZ PHARMACEUTICALS PLC | -3.1% |
|
CATALENT INC | -2.8% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.7% |